| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Director Deals - Silence Therapeutics PLC (SLN)
BFN
|
Mark Rothera, Chief Executive Officer, bought 3,600 shares in the company on the 1st December 2020 at a price of $5.99. The Director now holds 3,600 shares representing 0.00% of the shares in issue.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
|
|
|
|
|
|
